The Globe and Mail reported on Friday, May 12, edition that RBC Capital Markets analyst Darko Mihelic has reaffirmed his "sector perform" recommendation for Manulife Financial. The Globe's David Leeder writes that Mr. Mihelic bumped his share target ahead by $2 to $30. Analysts on average target the shares at $29.20. Mr. Mihelic says in a note: "Manulife's Q1/23 results came in line with our overall forecast, while our segment forecasts naturally had significant error being based on IFRS 4. Caveat aside, Asia seemed 'light' and sales continue to look a little challenged for that segment. We model Asia for more sales into next year and beyond, though under IFRS 17 this is not as impactful as before. We think core investment results may also be a touch under long-term expectations this year as markets are volatile and credit losses are likely." The Globe's Rob Carrick recommended buying Manulife on Oct. 15 when the shares were going for $22. The Globe reported on Feb. 3 that Credit Suisse analyst Joo Ho Kim rated Manulife "neutral." It was then worth $26.23. The Globe reported on Feb. 18 that Mr. Mihelic had reiterated his "sector perform" recommendation for Manulife when it could be had for $26.72.